Last reviewed · How we verify
furosemide administration — Competitive Intelligence Brief
marketed
Loop diuretic
Na-K-2Cl cotransporter (NKCC2)
Cardiovascular
Small molecule
Live · refreshed every 30 min
Target snapshot
furosemide administration (furosemide administration) — Unity Health Toronto. Furosemide inhibits sodium and chloride reabsorption in the loop of Henle, promoting diuresis and reducing fluid volume.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| furosemide administration TARGET | furosemide administration | Unity Health Toronto | marketed | Loop diuretic | Na-K-2Cl cotransporter (NKCC2) | |
| TORSEMIDE | TORSEMIDE | marketed | Loop Diuretic [EPC] | Na+/K+/2Cl- carrier system | 1993-01-01 | |
| Bumex | BUMETANIDE | marketed | Loop Diuretic [EPC] | Solute carrier family 12 member 1 | 1983-01-01 | |
| Edecrin | ETHACRYNIC ACID | Bausch Health | marketed | Loop Diuretic [EPC] | Glutathione S-transferase P | 1967-01-01 |
| Lasix | furosemide | Generic (originally Hoechst AG) | marketed | Loop Diuretic [EPC] | ATP-binding cassette sub-family G member 2, CDGSH iron-sulfur domain-containing protein 1, G-protein coupled receptor 35 | 1966-07-01 |
| FUROSEMIDE | FUROSEMIDE | marketed | Loop Diuretic [EPC] | 1966-01-01 | ||
| Furosemide (Diuretic) | Furosemide (Diuretic) | Jose J Zaragoza, MD MSc | marketed | Loop diuretic | Na-K-2Cl cotransporter (NKCC2) |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
- — TORSEMIDE · 10154963 · Formulation · US
- — Lasix · 9884039 · Method of Use · US
- — Lasix · 11433044 · Method of Use · US
- — Lasix · 12370168 · Formulation · US
- — Lasix · 10272064 · Formulation · US
- — Bumex · 11123319 · Formulation · US
- — Bumex · 11260038 · Method of Use · US
- — Bumex · 12329731 · Formulation · US
Sponsor landscape (Loop diuretic class)
- Sarfez Pharmaceuticals, Inc. · 3 drugs in this class
- B&A Therapeutics · 1 drug in this class
- Jose J Zaragoza, MD MSc · 1 drug in this class
- Ferrer Internacional S.A. · 1 drug in this class
- Heart Care Foundation · 1 drug in this class
- Instituto de Investigación Sanitaria Aragón · 1 drug in this class
- China National Center for Cardiovascular Diseases · 1 drug in this class
- Lakeland Regional Health Systems, Inc. · 1 drug in this class
- Larissa University Hospital · 1 drug in this class
- Assistance Publique - Hôpitaux de Paris · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- furosemide administration CI watch — RSS
- furosemide administration CI watch — Atom
- furosemide administration CI watch — JSON
- furosemide administration alone — RSS
- Whole Loop diuretic class — RSS
Cite this brief
Drug Landscape (2026). furosemide administration — Competitive Intelligence Brief. https://druglandscape.com/ci/furosemide-administration. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab